Stock PANC PANACOS PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

All News Panacos Pharmaceuticals, Inc.

Equities

PANC

US69811Q1067

Delayed OTC Markets
Other stock markets
 15:18:54 2024-04-23 EDT 		5-day change 1st Jan Change
0.000001 USD -.--% Intraday chart for Panacos Pharmaceuticals, Inc. -.--% -.--%

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Panacos Pharma : Panacos to Present at Bear Stearns Healthcare Conference
BU
Panacos Pharma : Panacos Reports Second Quarter 2007 Financial Results
BU
Panacos Pharma : Panacos Announces Five Presentations on its Antiviral Programs at International AIDS Society Conference
BU
Panacos Pharma : Panacos to Report Second Quarter Results for 2007
BU
Panacos Pharma : Panacos Secures $20 Million Debt Financing
BU
Panacos Pharma : Panacos Announces Substantial Antiviral Response in Bevirimat 250 mg Cohort, Data Support Further Dose Escalation in Phase 2b Study
BU
Panacos Pharma : Panacos to Present at Needham Biotech & Medtech Conference
BU
Panacos Pharma : Panacos to Present at Needham Biotech & Medtech Conference
BU
Panacos Pharma : Panacos to Present at Bear Stearns Biotech Confab
BU
Panacos Pharma : Preclinical Study Finds Protease Inhibitor-Resistant HIV May Have Reduced Potential to Develop Resistance to Panacos' Bevirimat
BU
Panacos Pharma : Panacos to Present at Bank of America Health Care Conference
BU
Panacos Pharma : Panacos Reports First Quarter 2007 Financial Results
BU
Panacos Pharma : Panacos to Present at Deutsche Bank Health Care Conference
BU
Panacos Pharma : Panacos to Report First Quarter Results for 2007
BU
Panacos Pharma : Panacos Announces New Board Member
BU
Panacos Pharma : Panacos to Present at CIBC World Markets Biotechnology & Specialty Pharmaceuticals Conference
BU
Panacos Pharma : Panacos Announces Bevirimat Phase 2b Dose Escalation Strategy
BU
Panacos Pharma : Panacos to Present at Citigroup Small & Mid-Cap Conference
BU
Panacos Pharma : Panacos to Present at Cowen Health Care Conference
BU
Panacos Pharma : Panacos Begins Phase 1 Clinical Study of Second Generation Maturation Inhibitor PA-040
BU
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. PANC Stock
  4. News Panacos Pharmaceuticals, Inc.
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW